Brazilian Corona variant P.1 in Great Britain
Six cases of the worrying coronavirus variant P.1 have been detected in the UK, which first appeared in the Brazilian city of Manaus. The British Minister of Health confirmed this in a press conference. It is particularly precarious that one of the identified cases could not be contacted and presumably does not know anything about the infection.
The British Minister of Health Matt Hancock confirmed six cases of the coronavirus mutation P.1 from Brazil in Great Britain in a press conference on March 1, 2021. Five of those affected and their families are in quarantine. One infected person is still missing.
Six cases of the P.1 variant in the UK
Coronavirus tests in Great Britain on February 12 and 13, 2021 detected the SARS-CoV-2 mutation P.1 from Brazil in six cases – three in England and three in Scotland. The variant was first discovered in the city of Manaus, where it caused violent outbreaks. “We identified these cases thanks to the advanced sequencing capabilities in the UK,” stressed the UK Health Minister, Hancock.
One of the mutation carriers is missing
Unfortunately, only five people affected could be informed about the dangerous mutation. “One of the six took a test but didn’t complete the contact details,” explains Hancock. The authorities are currently trying to find the person concerned. The Minister of Health asks for help from the English population.
How dangerous is the Brazilian variant of cornavirus?
A Brazilian-British research team from the “Center for Arbovirus Discovery, Diagnostics, Genomics and Epidemiology” has examined how dangerous the P.1 mutation of the SARS-CoV-2 coronavirus actually is. Accordingly, the variant is 1.4 to 2.2 times more contagious than the original version. In addition, there is an increased risk of the mutation that people who were already infected with the original version (wild type) will be infected again.
Many questions about P.1 are still open
The researchers warn that P.1 probably has the ability to undermine previously acquired immunities by the wild type. However, more studies are needed to examine the properties of the mutation in more detail. In addition, the research work can only be viewed as a pre-publication and has not yet been “peer reviewed” by independent experts. (vb)
Author and source information
This text complies with the requirements of specialist medical literature, medical guidelines and current studies and has been checked by medical professionals.
Diploma-Editor (FH) Volker Blasek
This article is for general guidance only and should not be used for self-diagnosis or self-treatment. He can not substitute a visit at the doctor.